Jacksonville South: 904-281-5757 | Jacksonville UNC: 904-281-5757 | Memphis: 901-843-1045 | Orlando Downtown: 407-425-5100 |
Orlando SODO: 407-722-5313
Jacksonville: 904-281-5757 | Memphis: 901-843-1045
Downtown Orlando: 407-425-5100 | Orlando SODO: 407-425-5100
Clostridium difficile colitis results from disruption of normal healthy bacteria in the colon, often from antibiotics. C. difficile can also be transmitted from person to person by spores. It can cause severe damage to the colon and even be fatal.
Infections caused by clostridium difficile colitis are on the rise and resistance to antibiotics is a growing problem, so there is intense interest in a vaccine that could protect patients from the pathogen, which is a leading cause of hospital-acquired infections. Ready to learn more about C. diff vaccinations? Click on a location near you to find currently enrolling Clostridium Difficile Colitis (C. diff) Vaccination Clinical Trials. Find out if a C. diff vaccination is right for you by using the appointment form to schedule a free consultation.
People who have illnesses or conditions requiring prolonged use of antibiotics, and the elderly, are at greater risk of acquiring this disease. The bacteria are found in the feces. People can become infected if they touch items or surfaces that are contaminated with feces and then touch their mouth or mucous membranes. Healthcare workers can spread the bacteria to patients or contaminate surfaces through hand contact. Therefore, this disease can also be spread to people who are frequently in the hospital or in medical offices.
Since opening our doors in 1996, CNS Healthcare has had the privilege of assisting in the development of some of the most widely prescribed medicines in the world. We continue to lead the way in providing the clinical research necessary to identify medications for the FDA to review and, once approved, physicians to prescribe. CNS has conducted thousands of clinical trials, improved millions of lives, and is proud to have helped in the FDA approval of nearly 100 new treatments.
